Synutra Int'l (SYUT) Reports Q3 EPS of $0.21

Go back to Synutra Int'l (SYUT) Reports Q3 EPS of $0.21

Synutra Reports Third Quarter Fiscal 2016 Financial Results

February 5, 2016 6:30 AM EST

QINGDAO, China and ROCKVILLE, Md., Feb. 5, 2016 /PRNewswire/ -- Synutra International, Inc. (Nasdaq: SYUT), ("Synutra" or the "Company"), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced financial results for the third quarter of fiscal 2016 ended December 31, 2015.

Mr. Liang Zhang, Chairman and CEO of Synutra, commented, "Our third quarter of fiscal 2016 results continued to reflect impacts from the competitive promotional environment and unfavorable foreign currency exchange rates. However, we were still able to achieve meaningful growth in margin expansion... More

Synutra Special Committee Engages Independent Financial Advisor and Legal Counsel in connection with "Going Private" Proposal

February 5, 2016 6:30 AM EST

QINGDAO, China and ROCKVILLE, Md., Feb. 5, 2016 /PRNewswire/ -- Synutra International, Inc. (Nasdaq: SYUT) ("Synutra" or the "Company"), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that the special committee of its board of directors (the "Board"), which is composed entirely of independent directors (the "Special Committee"), has retained Houlihan Lokey Capital, Inc. as the Special Committee's independent financial advisor and Cleary Gottlieb Steen & Hamilton LLP as its U.S. legal counsel in connection with its review and evaluation of the non-binding... More